Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron C Gonzalez Nelson

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Seminars in Cell & Developmental Biology|March 1, 2011
Interactions between non-identical prion proteinsAaron C Gonzalez Nelson, Eric D Ross
Headache|May 8, 2024
Safety, tolerability, and pharmacokinetics of a single orally inhaled dose of PUR3100, a dry powder formulation of dihydroergotamine versus intravenous dihydroergotamine: A Phase 1 randomized, double-blind study in healthy adultsSusan Bodie, Aidan K Curran, Aaron C Gonzalez-Nelson, et al.
Plos One|March 4, 2014
Increasing prion propensity by hydrophobic insertionAaron C Gonzalez Nelson, Kacy R Paul, Michelina Petri, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Seminars in Cell & Developmental Biology|March 1, 2011
Interactions between non-identical prion proteinsAaron C Gonzalez Nelson, Eric D Ross
Headache|May 8, 2024
Safety, tolerability, and pharmacokinetics of a single orally inhaled dose of PUR3100, a dry powder formulation of dihydroergotamine versus intravenous dihydroergotamine: A Phase 1 randomized, double-blind study in healthy adultsSusan Bodie, Aidan K Curran, Aaron C Gonzalez-Nelson, et al.
Plos One|March 4, 2014
Increasing prion propensity by hydrophobic insertionAaron C Gonzalez Nelson, Kacy R Paul, Michelina Petri, et al.
Pageof 1